Beta-lactamase inhibitor: Difference between revisions
Jump to navigation
Jump to search
m Protected "Beta-lactamase inhibitor": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
| Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
[[Image:Clavulanic acid structure.svg|thumb|left|[[Clavulanic acid]]]] | [[Image:Clavulanic acid structure.svg|thumb|left|[[Clavulanic acid]]]] | ||
| Line 13: | Line 13: | ||
{{PenicillinAntiBiotics}} | {{PenicillinAntiBiotics}} | ||
[[Category:Beta-lactamase inhibitors]] | [[Category:Beta-lactamase inhibitors]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WS}} | {{WS}} | ||
Revision as of 22:53, 8 August 2012
A beta-lactamase inhibitor is a drug given in conjunction with a beta-lactam antibiotic. Although the inhibitor does not usually have significant antibiotic activity on its own,[1] it still plays an important role by disabling or slowing down the action of beta-lactamase.
Beta-lactamase inhibitors in clinical use include clavulanic acid and its potassium salt (usually combined with amoxicillin or ticarcillin), sulbactam and tazobactam.
References
- ↑ "Beta-Lactamase Inhibitors". Department of Nursing of the Fort Hays State University College of Health and Life Sciences. October 2000. Retrieved 2007-08-17.